Open AccessValvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Author(s) -
R Zanettini,
Angelo Antonini,
Gemma Gatto,
Rosa Gentile,
Silvana Tesei,
Gianni Pezzoli
Publication year - 2007
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa054830
Subject(s) - medicine , disease , pergolide , dopamine , valvular heart disease , parkinson's disease , dopamine agonist , dopamine receptor , cardiology , dopaminergic
Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated with an increased risk of valvular heart disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom